Trial
NCT02370095
Treprostinil Sodium Inhalation for Patients At High Risk for ARDS
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of North Carolina, Chapel Hill
Collaborators
United Therapeutics
Condition
Respiratory Distress Syndrome, Adult
Intervention
Treprostinil Inhalation Solution
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-10-01